Nina Oestreicher

Articles by Nina Oestreicher

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)

ByKathryn Martin,Hope Rugo, MD,Gregory Vidal, MD, PhD,Nina Oestreicher,Deepa Lalla,Gillian Hanson,Daniel Drozd,Kristie Traverso,Dan DiPrimeo,Debu Tripathy, MD

April 18th 2022

Latest Updated Articles

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)
April 18th 2022

Trending on CancerNetwork

BNT113/Pembrolizumab Misses PFS End Point in HPV16+ Head and Neck Cancer

RYZ101 Improves Progression-Free Survival in Previously Treated GEP-NETs

Why CAR T-Cell Therapy Before Bispecifics May Be the Ideal Multiple Myeloma Sequence

Teclistamab Vs Talquetamab After Relapse on CAR T-Cell Therapy in Multiple Myeloma

How Might IMiD Holding Therapy Impact Outcomes in R/R Multiple Myeloma?